CRISPR Therapeutics AG
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $239.8M | $315.5M | $156.0M |
| Accounts Receivable | $2.6M | $3.2M | $339.0K |
| Inventory | — | — | — |
| Total Current Assets | $248.4M | $320.2M | $156.8M |
| Property, Plant & Equipment | $18.9M | $21.0M | $1.3M |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | $344.0K | $399.0K | $454.0K |
| Total Assets | $271.3M | $345.0M | $159.4M |
| Liabilities | |||
| Accounts Payable | $1.6M | $4.6M | $1.6M |
| Total Current Liabilities | $14.5M | $22.0M | $10.2M |
| Long-Term Debt | — | — | — |
| Total Liabilities | $83.5M | $112.1M | $124.0M |
| Stockholders' Equity | |||
| Retained Earnings | $-125.4M | $-57.1M | $-33.9M |
| Total Stockholders' Equity | $187.8M | $232.8M | $-29.1M |